>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Congressional Researchers Question IPAB

Tuesday, December 21, 2010

A recently obtained report authored by the non-partisan Congressional Research Service (CRS) raises questions about the Independent Payment Advisory Board (IPAB), a draconian Medicare cost-cutting mechanism created by the new health care reform law, the Patient Protection and Affordable Care Act (PPACA).

The reform law created the IPAB as a novel and aggressive mechanism to “reduce the per capita rate of growth in Medicare spending.” The Board, composed of 15 members appointed by the President, is charged with developing proposals to maintain Medicare spending below a targeted per capita growth rate.  In a process reminiscent of that used for the Defense Base Realignment and Closure (BRAC) Commission, the Board’s proposals receive special expedited and protected consideration by Congress.  The process spelled out in the statute creates a number of barriers that inhibit Congress’ ability to reject or defeat any proposed Medicare cuts.    

The CRS report highlights that the IPAB provision may be open to legal challenges because the law shifts the “balance of power to the executive branch and away from Congress.” The report also questions how the IPAB procedures will impact House and Senate parliamentary procedures and the constitutional rights of both chambers. 

Currently, the constitutionality of the Board is being challenged in federal district court in Arizona by the Goldwater Institute.

ASA opposed the inclusion of IPAB during the health system reform debate and currently supports repeal of the provision creating the Board.         

« Back to Washington Alerts